1. Home
  2. ESQ vs BBNX Comparison

ESQ vs BBNX Comparison

Compare ESQ & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

N/A

Current Price

$131.90

Market Cap

941.0M

Sector

Finance

ML Signal

N/A

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

N/A

Current Price

$16.33

Market Cap

897.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESQ
BBNX
Founded
2006
2015
Country
United States
United States
Employees
N/A
423
Industry
Commercial Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
897.6M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
ESQ
BBNX
Price
$131.90
$16.33
Analyst Decision
Buy
Buy
Analyst Count
3
15
Target Price
★ $142.67
$25.10
AVG Volume (30 Days)
128.7K
★ 1.1M
Earning Date
10-27-2026
10-27-2026
Dividend Yield
★ 0.61%
N/A
EPS Growth
14.20
★ 78.95
EPS
★ 4.48
N/A
Revenue
N/A
★ $100,251,000.00
Revenue This Year
$53.78
$25.22
Revenue Next Year
$47.38
$47.09
P/E Ratio
$29.46
★ N/A
Revenue Growth
N/A
★ 53.94
52 Week Low
$94.55
$8.80
52 Week High
$134.65
$32.71

Technical Indicators

Market Signals
Indicator
ESQ
BBNX
Relative Strength Index (RSI) 63.82 45.41
Support Level $113.87 $15.40
Resistance Level $133.94 $18.20
Average True Range (ATR) 4.06 1.62
MACD 0.54 -0.00
Stochastic Oscillator 76.60 25.71

Price Performance

Historical Comparison
ESQ
BBNX

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: